as a minimally invasive procedure and novel technique for the treatment of RCC. Conclusions: To our knowledge, this is the first case to date of bilateral RCC treated with simultaneous retroperitoneal laparoscopic nephron-sparing surgery (RLNSS). Here we indicate the feasibility of this management and discuss the advantages and disadvantages of this technique. Background: This study investigated the role of ZEB1 in vasculogenic mimicry (VM) formation and the interplay between VM and epithelial-mesenchymal transition (EMT). Methods: Ninety-two prostate cancer tissue specimens were stained by CD34 and periodic acid Schiff. Then, we stained ZEB1 protein in the consecutive sections. Moreover, prostate cancer cells were subjected to ZEB1 knockdown using ZEB1 siRNA and then to 3D culture assay. EMT related maker was also evaluated. Results: The data showed that the presence of VM and high ZEB1 expression were associated with higher Gleason score, TNM stage, and lymph node and distant metastases. ZEB1 knockdown reduced VM formation and the
Background:
The authors established a 125I-labeled replication-selective oncolytic adenovirus and human telomerase reverse transcriptase/prostate-specific antigen (125I-RSOAds-hTERT/PSA) oncolytic adenovirus marker and investigated the effects of different labeling conditions. This study also explored the possible mechanism whereby 125I-RSOAds-hTERT/PSA inhibited the proliferation of prostate cancer cells. Methods: N-bromosuccinimide (NBS) was used as an oxidant for 125I labeling, and various concentrations of oncolytic viruses and NBS were prepared to determine the optimal conditions for labeling. The effects of the
